Décision

UPC_CoA_464/2024, UPC_CoA_457/2024, UPC_CoA_458/2024, UPC_CoA_530/2024, UPC_CoA_532/2024, UPC_CoA_533/2024, UPC_CoA_21/2025, UPC_CoA_27/2025

Appeal RoP220.1

Date

25 novembre 2025

Langue

DE

Division

Court of Appeal, Luxembourg

N° de registre

UPC_CoA_464/2024, UPC_CoA_457/2024, UPC_CoA_458/2024, UPC_CoA_530/2024, UPC_CoA_532/2024, UPC_CoA_533/2024, UPC_CoA_21/2025, UPC_CoA_27/2025

N° d'affaire

UPC_CoA_464/2024, UPC_CoA_457/2024, UPC_CoA_458/2024, UPC_CoA_530/2024, UPC_CoA_532/2024, UPC_CoA_533/2024, UPC_CoA_21/2025, UPC_CoA_27/2025

Parties

Meril Italy Srl (Appellant in 464/2024 and Respondent in 530/2024),Meril GmbH (Appellant in 457/2024 and 21/2025 and Respondent in 532/2024 and 27/2025),Meril Life Sciences Pvt Ltd. (Appellant in 458/2024 and 21/2025 and Respondent in 533/2024 and 27/2025),Edwards Lifesciences Corporation (Appellant in 530/2024, 532/2024, 533/2024 and 27/2025 and Respondent in 464/2024, 457/2024, 458/2024 and 21/2025)

Brevets de la décision7
  • EP 3 646 825
  • EP 3 205 308
  • EP 2 731 552
  • WO 2013/012801
  • US 201161508456

Mots-clés

9

Notes personnelles

Connectez-vous pour ajouter des notes personnelles à cette décision.